127 Results

CHMP recommends approval for Dupixent for add-on maintenance treatment for severe asthma

 Added 19 days ago

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent (dupilumab),...

FDA approves first generic Advair Diskus to treat asthma and COPD.- Mylan

 Added 1 month ago

The FDA has approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment...

NICE recommends use of Fasenra in eosinophilic asthma.- AstraZeneca.

 Added 2 months ago

The National Institute for Health and Care Excellence has recommended that Fasenra (benralizumab), from AstraZeneca, be available to people with...

FDA approves ProAir Digihaler for asthma.- Teva.

 Added 2 months ago

Teva Pharmaceutical announced that the FDA has approved ProAir Digihaler (albuterol sulfate 117 mcg) inhalation powder, the first and only...

VR 475 did not meet endpoints in Phase III for treatment of asthma- Vectura

 Added 3 months ago

Vectura Group plc announces that its phase III study of VR 475 in adult and adolescent patients with severe uncontrolled...

GlaxoSmithKline files sBLA to expand indication of Nucala in eosinophilic asthma.- GSK.

 Added 4 months ago

GlaxoSmithKline announced the filing of a supplemental Biologics License Application (sBLA) to the FDA seeking an additional indication for the...

FDA approves Dupixent to treat moderate to severe asthma.-Sanofi + Regeneron.

 Added 5 months ago

The FDA has approved Dupixent (dupilumab) as add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older...

BORA trial shows long-term safety and efficacy of Fasenra in patients with eosinophilic asthma.-AstraZeneca

 Added 6 months ago

AstraZeneca announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as...

ERS 2018 | Pollution linked to new dangers for unborn babies

 Added 6 months ago

First evidence that soot from polluted air is reaching placenta.

Nucala study in eosinophilic asthma published in JACI.- GSK.

 Added 6 months ago

GlaxoSmithKline announced results from an indirect treatment comparison of the licensed doses of Nucala (mepolizumab), versus benralizumab and reslizumab in...

Load more